Factors influencing survival in sphingosine phosphate lyase insufficiency syndrome: a retrospective cross-sectional natural history study of 76 patients

Our results demonstrate that SPLIS is a phenotypically heterogeneous condition. We find that patients diagnosed with SPLIS nephropathy in the first year of life and patients presenting with prenatal findings represent two high-risk subgroups, whereas patients harboring the R222Q SGPL1 variant fare better than the rest. Time to progression from onset of proteinuria to end stage kidney disease varies from less than one month to five years, and kidney transplantation may be lifesaving.

Authors

Institutions

Publication Details

Journal
Orphanet Journal of Rare Diseases
Published
2024-09-27
DOI
https://doi.org/10.1186/s13023-024-03311-w
Citations
4
Primary Topic
Sphingolipid Metabolism and Signaling
Type
article
Field-Weighted Citation Impact
0.94

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Factors influencing survival in sphingosine phosphate lyase insufficiency syndrome: a retrospective cross-sectional natural history study of 76 patients

Zubair Khan, Nicole Davis Weaver, Gönül Büyükyılmaz, Tülay Güran et al.
4 citations
Orphanet Journal of Rare Diseases
Sphingolipid Metabolism and Signaling
0.94
article

Factors influencing survival in sphingosine phosphate lyase insufficiency syndrome: a retrospective cross-sectional natural history study of 76 patients

Zubair Khan, Nicole Davis Weaver, Gönül Büyükyılmaz, Tülay Güran, Christine Mincham, Nancy P. Keller, Ehtesham Khalid, Julie Deane Saba, Julian Midgley, Sam Mehr, Georgie Mathew, Khalid Alhasan, Indu Khosla, Kathrin Buder, Harry Lesmana, Hong Xu, Norbert Teig
article en
4 citations

Abstract

Our results demonstrate that SPLIS is a phenotypically heterogeneous condition. We find that patients diagnosed with SPLIS nephropathy in the first year of life and patients presenting with prenatal findings represent two high-risk subgroups, whereas patients harboring the R222Q SGPL1 variant fare better than the rest. Time to progression from onset of proteinuria to end stage kidney disease varies from less than one month to five years, and kidney transplantation may be lifesaving.

Orphanet Journal of Rare DiseasesVol. 19(1)
Cincinnati Children's Hospital Medical Center (US), Cleveland Clinic (US), Royal Children's Hospital (AU), Ochsner Health System (US), Christian Medical College, Vellore (IN), University of California, San Francisco (US), Princess Margaret Hospital for Children (AU), Alberta Children's Hospital (CA), King Saud University (SA), Memorial Ankara Hospital (TR), University Children's Hospital Tübingen (DE), University Children's Hospital Zurich (CH), Education and Research Institute (US), SRCC Children’s Hospital (IN), Children's Hospital of Fudan University (CN), Perth Children's Hospital, Marmara University (TR), Ruhr University Bochum (DE)
National Institutes of Health, National Institute of Child Health and Human Development, Eunice Kennedy Shriver National Institute of Child Health and Human Development
Good health and well-being
Openalex Percentile: Top 25%
Sphingolipid Metabolism and Signaling
0.94
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.